ICP Consultant Connection Newsletter

ICP's newsletter is published monthly and provides industry updates and regulations. If you would like to receive these newsletters in your inbox, please sign up using the form below.



 

January 2017 Issue

  • Understanding Hypoglycemia
  • Psoriatic Arthritis (PsA)
  • Resident Rights
  • Oxycodone IR VS Oxycodone ER: Know the Difference
Web Version    Print PDF Version

July 2016 Issue

  • More Than One Good Reason to Use Skin Prep
  • Diabetes Care: A Paradigm Shift is Underway
  • Webinar
  • Revised Warnings for Metformin
  • What is Specialty Pharmacy?

Web Version    Print PDF Version

May 2016 Issue

  • Updated Pressure Stages and Terminology Changes Announced by NPUAP
  • Partially Filled Vials and Syringes in Sharps Containers are a Key Source of Drugs for Diversion
  • e-Prescribing of Controlled Substances
  • Webinar

Web Version    Print PDF Version

March 2016 Issue

  • Body Composition and Wounds
  • Long Term Care Advise ERR
  • 2016 National Patient Safety Goals for Long-Term Care
  • The importance of using the MAR/eMAR
  • Avandia, not Coumadin
  • Could this happen at your facility? ..
  • Nurses ranked most trustworthy profession

Web Version    Print PDF Version

November 2015 Issue

  • What is Eczema
  • ICP of Tiffin and Masons Awarded Accreditation From The Joint Commission
  • CDC announces $20 million to fi ght prescription drug abuse
  • Flu Season Is Off To A Slow Start: CDC
  • The Power of Language
  • Jody Bouillon of ICP, Inc. Awarded CEAL Certification

September 2015 Issue

  • Partnership to Improve Dementia Care in Nursing Homes
  • Aspirin NSAIDs Can Cause Heart Attacks or Strokes 
  • At risk: Obstructive sleep apnea patients 
  • National Alert on Potentially Fatal Dosing Due to Measurement Devices 
Web Version    Print PDF Version

July 2015 Issue

  • Choking vs. CPR: Correlation to Code Status
  • Guidelines For the Treatment of High Blood Cholesterol
  • Guidelines For Thyroid Disease Screening
Web Version    Print PDF Version

April 2015 Issue

  • Preventing Heart Failure Remission
  • Preventing Hospital Admissions in Long-term Care Patients with COPD
  • ICP Educators Speak at OHCA Convention
  • CMS announces release of 2015 Impact Assessment of Quality Measures Report
Web Version    Print PDF Version

February 2015 Issue

  • Efficacy of High Dose Influenza Vaccine in the Elderly
  • An Overview of Ohio LPN IV Changes
  • What is the current influenza vaccination coverage rate among healthcare personnel (HCP)?
  • Coverage Update on  Prevnar and Pneumovax Pneumococcal Vaccines
  • Continuing Education Webinars
Web Version    Print PDF Version

December 2014 Issue

  • Antibiogram Could Improve Antibiotic Effectiveness and Help Address Antibiotic Resistance
  • Difficult Conversation: Tips for Starting a Hospice Conversation 
  • New Year, New Outlook, New Habits: Welcome 2015!
  • Breaking News: National Pressure Ulcer Advisory Panel (NPUAP)
  • New “Hand Check” White Paper Hot off the Press!
  • Promoted to Position of Director of Pharmacy
Web Version    Print PDF Version

November 2014 Issue

  • Richard Sandilands, ICP Executive Vice President Retires
  • Introducing Craig Meier RPh, ICP Executive Vice President
  • Storage of Refrigerated Medications
  • Changes with heparin labels
  • Helping Them Adapt
  • Future devices for U-500 insulin 
Web Version    Print PDF Version

October 2014 Issue

  • CDC Advisers Recommend Elderly Receive Both Prevnar and Pneumovax Pneumococcal Vaccines
  • 3,100 patients notified of pen reuse
  • Everyone Needs a Flu Vaccine
  • NeutroPhase® Skin and Wound Cleanser
  • Hypergel Water Based Wound Dressing
  • Hydrocodone Products Moving to Schedule II
  • Nuedexta-Neulasta mix-ups
  • OBN on LPN IV Role
Web Version    Print PDF Version

September 2014 Issue

  • From the hospital to long-term care: Protecting vulnerable patients during transitions of care
  • Latta, Ohio delegation send letter to DEA 
     
Web Version    Print PDF Version

August 2014 Issue

  • EHOB®'s PVC and PVC/PU Materials Resist Bacterial Growth In Mattresses
  • Drug Shortages
  • Preventing Infection from the Misuse of Vials
  • Genes: Does One Size Fit All
  • Copier Data Security
     
Web Version    Print PDF Version

June - July 2014 Issue

  • Silent Stealers of Sight
  • Docusate Sodium
  • FDA Warns of Next-Day Impairment with Lunesta
  • Appropriate treatments for agitation and restlessness in hospice patients
  • Healthy Feet - Healthy People
  • Tramadol becomes a Controlled Substance
Web Version    Print PDF Version

May 2014 Issue

  • Continuing Education Update
  • Comparing Antidepressants
  • Microsoft XP Support Termination, HIPAA Security Rule
  • Benefits of a Healthy Mouth

 
Web Version    Print PDF Version

March 2014 Issue

  • Archaic Apothecary Strengths Confused
  • New Extended-Release Namenda Compared to Immediate-Release Formulation
  • Daliresp
  • Effectiveness of Calcium Supplements for Treating Hypocalcemia
Web Version    Print PDF Version

January / February 2014 Issue

  • Ohio Nurse Practice Act Updates 2013
  • As U-500 insulin safety concerns mount, rethink safe use of strengths above U-100
  • Flomax® (tamsulosin) for Urinary Issues in Women
  • Gut Microbes  - Rheumatoid Arthritis
  • New Treatment Guidelines for Dyslipidemia
  • CE for Nurses
Web Version    Print PDF Version

November 2013 Issue

  • November 2013 IssueNovember is National Diabetes Month:  A Snapshot of Assessing Diabetic Foot Ulcers
  • Dry Eye Syndrome
  • FDA requiring Color Changes to the Writing on Duragesic Pain Patches
  • Indications for Magnesium Oxide and Follow-up
  • Melatonin: Does it help in the treatment of insomnia?
Web Version    Print PDF Version

October 2013 Issue

  • Zinc and its Role in Wound Care
  • Medications That Increase Ammonia Levels and How to Treat Hyperammonemia
  • Effects of Vitamin C on Iron Absorption
  • FDA strengthens warnings on long-acting opiods
  • Fluoroquinclones: Risk of permanent nerve damage

Web Version     Print PDF Version

September 2013 Issue

  • ICP's Growth and Expansion
  • FDA Approves Oral Treatment for Multiple Sclerosis
  • Asprin in Stroke Patients: Does Dose Matter?
  • Guidance on Fentanyl Patch Disposal
  • MultiTasking
  • Acetaminophen Linked to Rare, Serious Skin Reactions

Web Version     Print PDF Version

August 2013 Issue

  • Business Associates and HIPAA Final Rule Compliance Date
  • Decreasing Heart Failure Readmissions
  • Vitamin D Supplementation
  • Opioid Induced Constipation

Web Version     Print PDF Version

July 2013 Issue

  • ICD-10. It's closer than it seems.
  • Asprin 81 mg versus Asprin 325 mg
  • The Power Of Words
  • Systems Based approach to a Quality Care Environment
Web Version     Print PDF Version

June 2013 Issue

  • Drugs In the Aging Body: Just What Goes On When
    You Swallow that Pill?
  • Tips to quench thirst:Elderly Dehydration Prevention
  • Nursing homes expected to miss reduction goal by15%
  • FDA: Samsca
  • FDA: Potiga

April  2013 Issue

  • Should an Ace Inhibitor (ACEI) ever be combined with an Angiotensin II Receptor Blocker (ARB) or a Renin Inhibitor?
  • Eliquis (apixaban) A new anticoagulant for treatment of Atrial Fibrillation
  • Look-Alike / Sound-Alike Medications
  • Cold or Allergies: How to Tell
  • FDA Alert: Azithromycin - Risk of Potentially Fatal Heart Rhythms

Web Version      Print PDF Version

January / February 2013

  • Institutional Care Pharmacy of Tiffin Awarded Accreditation From The Joint Commission
  • Honesty Ratings of Pharmacists Second Only to Nurses
  • Nursing Role in Reducing Unnecessary Medications
  • Skin Basics

Web Version      Print PDF Version

December 2012 Issue

  • 2012 ABS Beers List Update
  • Osteoporosis Prevention, Detection and Treatment
  • Preparing for Influenza Season
  • Medical Food

Web Version       Print PDF Version

November 2012 Issue

  • Stop the Rash...Preventing IAD
  • Unnecessary Drugs Part 3: Avoiding Citations
  • Zostavax: The Shingle Vaccine
  • Second Generation Antipsychotics - Better, Not Perfect

October 2012 Issue

  • Autumn is in the Air...So is Influenza
  • Unnecessary Drugs: Part 2: Situations in which an unnecessary drug citation could be given

September 2012 Issue

  • Injections Made Easier
  • Infection Control: Stopping the Spread of Clostridium Difficile
  • Unnecessary Drugs: Part 1: Just what is an unnecessary drug?

August 2012 Issue

  • Statin Medications No Longer Require Routine Lab Monitoring
  • New Drug Update: Dificid® (fidaxomicin)
  • Falls-Everyone’s Responsibility!
  • Usage of Flomax® (tamsulosin) in Women

June/July 2012 Issue

  • James H. Vogel Scholarship Award
  • Mom Hopes Son's Overdose Spurs Prevention Efforts
  • Combating Constipation in the Elderly
  • Medications To Avoid In Heart Failure

May 2012 Issue

  • All is not as it seems…Caution: drug names that end with the letter “L.”
  • Attention: Section M – Skin Conditions Item Set Changes
  • Acid Suppression Therapy Linked to C. Diff Infections
  • Five Things Physicians and Patients Should Question

April 2012 Issue

  • New Once Weekly Treatment Option For Type 2 Diabetes
  • Nursing Consideration for the Patient Taking Anxiolytics
  • Multi-dose vials
  • FDA NEWS RELEASE: FDA Announces Safety Changes In Labeling For Some Cholesterol-Lowering Drugs

March 2012 Issue

  • ICP Expands South
  • Comparing Anticoagulants for treatment of Atrial Fibrillation
  • Can Vitamin C Be Used To Prevent Urinary Tract Infections?
  • Nuedexta (Dextromethorphan 20mg/ Quinidine 10mg)
  • COPD Management

January/February 2012 Issue

  • Future EHR users
  • Yielding Concerns on Yaz
  • Simple Wound Care Time Saving Tips
  • Defend Against Fraud
  • Bedtime Dosing of Blood Pressure Medications